Meridian Medical Products Ltd - Accounts to registrar (filleted) - small 18.2

Meridian Medical Products Ltd - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v21.1.6.35 07849992 director 1.1.20 31.12.20 31.12.20 0 0 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure078499922019-12-31078499922020-12-31078499922020-01-012020-12-31078499922018-12-31078499922019-01-012019-12-31078499922019-12-3107849992ns16:EnglandWales2020-01-012020-12-3107849992ns15:USDollar2020-01-012020-12-3107849992ns11:Director12020-01-012020-12-3107849992ns11:PrivateLimitedCompanyLtd2020-01-012020-12-3107849992ns11:SmallEntities2020-01-012020-12-3107849992ns11:AuditExempt-NoAccountantsReport2020-01-012020-12-3107849992ns11:SmallCompaniesRegimeForDirectorsReport2020-01-012020-12-3107849992ns11:SmallCompaniesRegimeForAccounts2020-01-012020-12-3107849992ns11:FullAccounts2020-01-012020-12-310784999212020-01-012020-12-3107849992ns11:CompanySecretary12020-01-012020-12-3107849992ns11:RegisteredOffice2020-01-012020-12-3107849992ns6:CurrentFinancialInstruments2020-12-3107849992ns6:CurrentFinancialInstruments2019-12-3107849992ns6:Non-currentFinancialInstruments2020-12-3107849992ns6:Non-currentFinancialInstruments2019-12-3107849992ns6:ShareCapital2020-12-3107849992ns6:ShareCapital2019-12-3107849992ns6:RetainedEarningsAccumulatedLosses2020-12-3107849992ns6:RetainedEarningsAccumulatedLosses2019-12-3107849992ns6:IntangibleAssetsOtherThanGoodwill2020-01-012020-12-3107849992ns6:PatentsTrademarksLicencesConcessionsSimilar2020-01-012020-12-3107849992ns6:IntangibleAssetsOtherThanGoodwill2019-12-3107849992ns6:IntangibleAssetsOtherThanGoodwill2020-12-3107849992ns6:IntangibleAssetsOtherThanGoodwill2019-12-3107849992ns6:CurrentFinancialInstrumentsns6:WithinOneYear2020-12-3107849992ns6:CurrentFinancialInstrumentsns6:WithinOneYear2019-12-3107849992ns6:AfterOneYearns6:Non-currentFinancialInstruments2020-12-3107849992ns6:AfterOneYearns6:Non-currentFinancialInstruments2019-12-31
REGISTERED NUMBER: 07849992 (England and Wales)












UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2020

FOR

MERIDIAN MEDICAL PRODUCTS LTD

MERIDIAN MEDICAL PRODUCTS LTD (REGISTERED NUMBER: 07849992)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 31 December 2020




Page

Company information 1

Statement of financial position 2

Notes to the financial statements 4


MERIDIAN MEDICAL PRODUCTS LTD

COMPANY INFORMATION
for the Year Ended 31 December 2020







DIRECTOR: Ms M T Vrina





SECRETARY: KPM Consulting Ltd





REGISTERED OFFICE: Langley House
Park Road
London
N2 8EY





REGISTERED NUMBER: 07849992 (England and Wales)





ACCOUNTANTS: Accura Accountants Ltd
Langley House
Park Road
East Finchley
London
N2 8EY

MERIDIAN MEDICAL PRODUCTS LTD (REGISTERED NUMBER: 07849992)

STATEMENT OF FINANCIAL POSITION
31 December 2020

31.12.20 31.12.19
Notes $    $    $    $   
FIXED ASSETS
Intangible assets 4 11,400 15,200

CURRENT ASSETS
Debtors 5 2,420,446 2,381,101
Cash at bank 6,660 7,344
2,427,106 2,388,445
CREDITORS
Amounts falling due within one year 6 1,830,884 1,830,802
NET CURRENT ASSETS 596,222 557,643
TOTAL ASSETS LESS CURRENT
LIABILITIES

607,622

572,843

CREDITORS
Amounts falling due after more than one
year

7

675,691

651,491
NET LIABILITIES (68,069 ) (78,648 )

CAPITAL AND RESERVES
Called up share capital 1,587 1,587
Retained earnings (69,656 ) (80,235 )
SHAREHOLDERS' FUNDS (68,069 ) (78,648 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2020.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2020 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MERIDIAN MEDICAL PRODUCTS LTD (REGISTERED NUMBER: 07849992)

STATEMENT OF FINANCIAL POSITION - continued
31 December 2020


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 7 September 2021 and were signed by:





Ms M T Vrina - Director


MERIDIAN MEDICAL PRODUCTS LTD (REGISTERED NUMBER: 07849992)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 31 December 2020

1. STATUTORY INFORMATION

Meridian Medical Products Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of ten years.

Depreciation
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives.

Trade Marks and other intangibles Over 10 years

Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset , with the net amounts presented in the financial statements , when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets and liabilities
Basic financial assets, and liabilities are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets and liabilities classified as receivable or payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method. Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities


MERIDIAN MEDICAL PRODUCTS LTD (REGISTERED NUMBER: 07849992)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 December 2020

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2019 - NIL).

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
$   
COST
At 1 January 2020
and 31 December 2020 38,000
AMORTISATION
At 1 January 2020 22,800
Charge for year 3,800
At 31 December 2020 26,600
NET BOOK VALUE
At 31 December 2020 11,400
At 31 December 2019 15,200

MERIDIAN MEDICAL PRODUCTS LTD (REGISTERED NUMBER: 07849992)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 December 2020

5. DEBTORS
31.12.20 31.12.19
$    $   
Amounts falling due within one year:
Trade debtors 1,565,481 1,565,481
Other debtors 458 1,081
1,565,939 1,566,562

Amounts falling due after more than one year:
Other debtors 854,507 814,539

Aggregate amounts 2,420,446 2,381,101

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.20 31.12.19
$    $   
Trade creditors 1,830,135 1,830,136
Other creditors 749 666
1,830,884 1,830,802

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.12.20 31.12.19
$    $   
Other creditors 675,691 651,491